Diabetic peripheral sensory loss is a major risk factor for diabetic foot ulceration but may remain clinically silent and undetected when screening relies on symptoms alone. In remote primary-care settings, low-cost objective neurological assessment is particularly important. Objective to estimate the prevalence and plantar distribution of monofilament-defined loss of protective sensation (LOPS) and explore its associations with selected demographic, clinical, and neuropathic symptom variables among adults with type 2 diabetes mellitus (T2DM) in Fakfak, Eastern Indonesia. Methods a cross-sectional observational study was conducted among 57 adults with T2DM attending Puskesmas Fakfak Tengah. Six plantar sites on both feet were assessed using a 10-g Semmes-Weinstein monofilament. LOPS was defined as inability to perceive the monofilament at ≥1 site. Descriptive statistics and exploratory Fisher’s exact or chi-square tests were performed, with odds ratios (ORs), 95% confidence intervals (CIs), and two-sided p values. Results mean age was 53.21 ± 11.41 years, and 71.9% were women. Mean random blood glucose was 211.67 ± 84.24 mg/dL, while 56.1% had hypertension. LOPS was identified in 17/57 participants (29.8%; 95% CI 19.5–42.7%). Loss of perception was most frequent at the right first and fifth metatarsal sites (17.5% each) and left fifth metatarsal site (14.0%). Tingling, burning/pain, numbness, and previous diabetic foot wounds were reported by 45.6%, 19.3%, 22.8%, and 8.8%, respectively. Numbness was associated with LOPS (OR 3.97, 95% CI 1.08–14.53; p=0.043). Conclusions nearly one-third of adults with T2DM had objective LOPS on 10-g monofilament screening. These findings support routine objective foot screening in primary care, particularly where symptom reporting may be incomplete. Monofilament testing should complement broader neurological, vascular, and structural foot assessment.